Identification of Potential Drug Targets of Broad-Spectrum Inhibitors with a Michael Acceptor Moiety Using Shotgun Proteomics
Open Access
Abstract
The Michael addition reaction is a spontaneous and quick chemical reaction that is widely applied in various fields. This reaction is performed by conjugating an addition of nucleophiles with α, β-unsaturated carbonyl compounds, resulting in the bond formation of C-N, C-S, C-O, and so on. In the development of molecular materials, the Michael addition is not only used to synthesize chemical compounds but is also involved in the mechanism of drug action. Several covalent drugs that bond via Michael addition are regarded as anticarcinogens and anti-inflammatory drugs. Although drug development is mainly focused on pharmaceutical drug discovery, target-based discovery can provide a different perspective for drug usage. However, considerable time and labor are required to define a molecular target through molecular biological experiments. In this review, we systematically examine the chemical structures of current FDA-approved antiviral drugs for potential Michael addition moieties with α, β-unsaturated carbonyl groups, which may exert an unidentified broad-spectrum inhibitory mechanism to target viral or host factors. We thus propose that profiling the targets of antiviral agents, such as Michael addition products, can be achieved by employing a high-throughput LC-MS approach to comprehensively analyze the interaction between drugs and targets, and the subsequent drug responses in the cellular environment to facilitate drug repurposing and/or identify potential adverse effects, with a particular emphasis on the pros and cons of this shotgun proteomic approach.Keywords
Funding Information
- Chang Gung Memorial Hospital (BMRP416, CMRPD1G0301‐3, CMRPD1F0581‐3, and CMRPD1K0241‐2)
- Ministry of Science and Technology (106‐2320‐B‐182‐004‐MY3, 106‐ 2811‐B‐182‐011, 106‐2632‐B‐182‐001, 488 107‐2811‐B‐182‐512, 108‐2320‐B‐182‐039‐, 109‐2320‐B‐182‐026‐MY3, 109‐2327‐B‐182‐002, and 489 109‐2327‐B‐182‐003, MOST 492 110‐2634‐F‐182‐001、MOST 109‐2327‐B‐182‐002)
- Ministry of Education (The Featured Areas Research Centre Program within the framework of the Higher Education Sprout Project)
This publication has 95 references indexed in Scilit:
- Foot-and-Mouth Disease Virus 3C Protease Induces Fragmentation of the Golgi Compartment and Blocks Intra-Golgi TransportJournal of Virology, 2013
- Tipranavir in the Protease Inhibitors ArenaDrugs in R&D, 2011
- Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010Emerging Infectious Diseases, 2011
- The higher barrier of darunavir and tipranavir resistance for HIV-1 proteaseBiochemical and Biophysical Research Communications, 2011
- Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765Blood, 2011
- Oseltamivir-resistant pandemic H1N1 influenzaCanadian Medical Association Journal, 2011
- Protein Modification by Acrolein: Formation and Stability of Cysteine AdductsChemical Research in Toxicology, 2009
- BioMagResBank (BMRB) as a partner in the Worldwide Protein Data Bank (wwPDB): new policies affecting biomolecular NMR depositionsJournal of Biomolecular NMR, 2008
- An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein databaseJournal of the American Society for Mass Spectrometry, 1994
- AciclovirDrugs, 1994